Search results for "Blood"
Article
Single-Domain Antibodies for Brain Targeting
Their ability to permeate across the blood brain barrier is receiving industrial interest for neurological and neuro-oncological indications.
Going single domain
Biologic therapies such as mon…
Article
The Evolving Role of Starting Materials in Cell and Gene Therapy
CBC is complete blood count. The collection of healthy donor cells is also subject to considerable variability, and a well-established donor center will be aware of the many factors that impact WBC co…
Article
Emerging Therapies Test Existing Bioanalytical Methods
Cellular therapy, the transfer of live cells with a specific function to a patient to treat/cure a disease, was first successfully used in humans in the early 19th century in the form of blood transfu…
Article
Applications of Surface Plasmon Resonance for Detection of Bispecific Antibody Activity
Bispecific antibodies are also considered an effective platform for the delivery of therapeutic antibodies across the blood-brain barrier (2). This suggests that in certain cases, bispecific antibodie…
Article
Report from the Eighth International Plasma Product Biotechnology Meeting Melia Salinas, Lanzarote, Spain
In the Pathogen Safety session an illustrative presentation was given by Jun Adan-Kubo from the Japanese Blood Products Organization. He elaborated on the mechanism of virus removal in nano-filtration…
Article
Milestones and Moderate Progress in 2012 Drug Approvals
GLP-2 is known to promote increased intestinal blood flow, enhanced absorption of nutrients and maintenance of the small intestinal mucosa, hence the basis of product development as a treatment for sh…
Article
Design Considerations for a Commercial Cell and Gene Therapy Facility
Single-use systems are technologies that are widely used in the bioprocessing and blood processing industries to protect product from contamination, and these systems are also appropriately sized for …
Article
3rd BioProcessing Asia Preview: Q&A with John Curling
The program always covers the entire biopharmaceutical spectrum from antibodies and blood plasma products to vaccines as well as biosimilars development. BioProcessing Asia also differentiates itself …
Article
From Darwin to Recombinant Fc Multimers
BPL manufactures a range of products from blood plasma and has been a regular attendee at PPB. Perkins emphasized the importance of having a healthy plasma fractionation industry not just for the pati…
Article
Ensuring the Quality of Biologicals
(first published in 1980) saw the elaboration of monographs that concerned substances extracted from animal tissues (such as heparins) and human blood and plasma-derived medicinal products. In 1992, a…